Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults

Citation metadata

From: PLoS ONE(Vol. 8, Issue 8)
Publisher: Public Library of Science
Document Type: Article
Length: 6,419 words
Lexile Measure: 1650L

Document controls

Main content

Abstract :

In this study we used stool profiling to identify intestinal bacteria and metabolites that are differentially represented in humans with colorectal cancer (CRC) compared to healthy controls to identify how microbial functions may influence CRC development. Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. The V4 region of the 16s rRNA gene was pyrosequenced and both short chain fatty acids and global stool metabolites were extracted and analyzed utilizing Gas Chromatography-Mass Spectrometry (GC-MS). There were no significant differences in the overall microbial community structure associated with the disease state, but several bacterial genera, particularly butyrate-producing species, were under-represented in the CRC samples, while a mucin-degrading species, Akkermansia muciniphila, was about 4-fold higher in CRC (p

Source Citation

Source Citation   

Gale Document Number: GALE|A478414245